ImmunoGen: Q4 Earnings Snapshot
By AP News
Published - Mar 01, 2023, 06:48 AM ET
Last Updated - Jun 22, 2023, 06:47 PM EDT
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — ImmunoGen Inc. (IMGN) on Wednesday reported a loss of $59 million in its fourth quarter.
On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 23 cents.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The drug developer posted revenue of $41.2 million in the period, also surpassing Street forecasts. Eight analysts surveyed by Zacks expected $17.7 million.
